A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin

Cancer

Volumn 94, Issue 2, 2002, Pages 452-458

  Dimopoulou, Ioanna ^a,d   Galani, Heleni ^b   Dafni, Urania ^c   Samakovli, Anastasia ^a   Roussos, Charis ^a   Dimopoulos, Meletios A ^b  

^a EVANGELISMOS HOSPITAL   (Greece)

^b ALEXANDRA HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d NONE   (Greece)

Author keywords

Adverse effects; Carboplatin; Chest X ray; Diffusion capacity for carbon monoxide; Lung toxicity; Paclitaxel; Pulmonary function tests; Respiratory symptoms

Indexed keywords

CARBON MONOXIDE; CARBOPLATIN; PACLITAXEL;

ADULT; AGED; ARTERIAL GAS; ARTICLE; CANCER; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LUNG ALVEOLUS; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; LUNG TOXICITY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARTERIES; CARBON MONOXIDE; CARBOPLATIN; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; LUNG DISEASES; MALE; MIDDLE AGED; OVARIAN NEOPLASMS; PACLITAXEL; PROSPECTIVE STUDIES; PULMONARY DIFFUSING CAPACITY; RESPIRATORY FUNCTION TESTS; URINARY BLADDER NEOPLASMS;

EID: 0037080428     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10182     Document Type: Article

References (26)

1. The taxanes: An update
2. Toxicity of chemotherapy
3. Pulmonary complications of cancer therapy
4. Pneumonitis related to treatment with paclitaxel
5. Pulmonary infiltrates following administration of paclitaxel
6. Paclitaxel-induced acute bilateral pneumonitis
7. Pulmonary changes in patients with lymphoma who receive paclitaxel
8. Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer
9. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs
10. Single-breath carbon monoxide diffusion capacity (transfer factor). Recommendations for a standard technique - 1995 update
11. Evaluation of impairment/disability secondary to respiratory disorders
12. Presentation of pulmonary function test to the clinician
13. Serial pulmonary function tests in patients treated with low-dose amiodarone
14. A prospective study of pulmonary function in patients receiving mitomycin
15. Pulmonary function in patients receiving long-term low-dose methotrexate
16. Paclitaxel-induced cell-mediated hypersensitivity pneumonitis. Diagnosis using leukocyte migration test, bronchoalveolar lavage and transbronchial lung biopsy
17. Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel
18. Successful parenteral desensitization to paclitaxel
19. Histamine release in dogs by cremophor E1 and its derivatives: Oxethylated oleic acid is the most effective constituent
20. Phase I/IIa study of concurrent paclitaxel and cisplatin with radiation therapy in locally advanced non-small cell lung cancer: Analysis of early and late pulmonary morbidity
21. New developments and approaches in the platinum arena
22. Clinical features of hypersensitivity reactions to carboplatin
23. Pulmonary function changes in lung-cancer patients treated with radiation with or without carboplatin
24. Role of single-breath carbon monoxide diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients
25. Effects of bleomycin on pulmonary function in man
26. Effect of treatment for Hodgkin's disease on pulmonary function: Results of a prospective study